PEZZICOLI, GAETANO
PEZZICOLI, GAETANO
DIPARTIMENTO INTERDISCIPLINARE DI MEDICINA
A Glimpse in the Future of Malignant Mesothelioma Treatment
2021-01-01 Pezzicoli, G.; Rizzo, M.; Perrone, M.; Minei, S.; Mutti, L.; Porta, C.
Abstract 2012: In vitro validation of tumor-derived large extracellular vesicles isolation and characterization as suitable tool for liquid biopsy
2021-01-01 Pezzicoli, Gaetano; Lovero, Domenica; Tucci, Marco; Porta, Camillo; Mannavola, Francesco
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives
2021-01-01 Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C.
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications
2022-01-01 Lauricella, Eleonora; Mandriani, Barbara; Cavallo, Federica; Pezzicoli, Gaetano; Chaoul, Nada; Porta, Camillo; Cives, Mauro
Beyond ras and braf: Her2, a new actionable oncotarget in advanced colorectal cancer
2021-01-01 Guarini, C.; Grassi, T.; Pezzicoli, G.; Porta, C.
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors
2021-01-01 Pezzicoli, Gaetano; Triggiano, Giacomo; Sergi, Maria Chiara; Mannavola, Francesco; Porta, Camillo; Tucci, Marco
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification
2023-01-01 Rizzo, Mimma; Caliò, Anna; Brunelli, Matteo; Pezzicoli, Gaetano; Ganini, Carlo; Martignoni, Guido; Porta, Camillo Guglielmo Giuseppe
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
2022-01-01 Marconcini, Riccardo; Pezzicoli, Gaetano; Stucci, LUIGIA STEFANIA; Sergi, MARIA CHIARA; Lospalluti, Lucia; Porta, Camillo; Tucci, Marco
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition
2020-01-01 Mannavola, Francesco; Pezzicoli, Gaetano; Tucci, Marco
Il trattamento del carcinoma renale avanzato: un aggiornamento [The Treatment of Metastatic Renal Cell Carcinoma: An Update]
2023-01-01 Pezzicoli, Gaetano; Ganini, Carlo; Re Sartò, Giulia Vanessa; Pirovano, Marta; Cosmai, Laura; Porta, Camillo
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma
2022-01-01 Rizzo, Mimma; Varnier, Luca; Pezzicoli, Gaetano; Pirovano, Marta; Cosmai, Laura; Porta, Camillo
Large extracellular vesicles—a new frontier of liquid biopsy in oncology
2020-01-01 Pezzicoli, G.; Tucci, M.; Lovero, D.; Silvestris, F.; Porta, C.; Mannavola, F.
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
2020-01-01 Internò, Valeria; Tucci, Marco; Pezzicoli, Gaetano; Silvestris, Franco; Porta, Camillo; Mannavola, Francesco
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management
2022-01-01 Rizzo, Mimma; Pezzicoli, Gaetano; Santoni, Matteo; Caliò, Anna; Martignoni, Guido; Porta, Camillo
Playing the devil’s advocate: Should we give a second chance to mTOR inhibition in renal clear cell carcinoma? – ie strategies to revert resistance to mtor inhibitors
2021-01-01 Pezzicoli, G.; Filoni, E.; Gernone, A.; Cosmai, L.; Rizzo, M.; Porta, C.
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations
2024-01-01 Rizzo, Mimma; Pezzicoli, Gaetano; Ganini, Carlo; Carone, Luisa; Caliò, Anna; Brunelli, Matteo; Cosmai, Laura; Porta, Camillo
Uterine carcinosarcoma: An overview
2021-01-01 Pezzicoli, G.; Moscaritolo, F.; Silvestris, E.; Silvestris, F.; Cormio, G.; Porta, C.; D'Oronzo, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Glimpse in the Future of Malignant Mesothelioma Treatment | 1-gen-2021 | Pezzicoli, G.; Rizzo, M.; Perrone, M.; Minei, S.; Mutti, L.; Porta, C. | |
| Abstract 2012: In vitro validation of tumor-derived large extracellular vesicles isolation and characterization as suitable tool for liquid biopsy | 1-gen-2021 | Pezzicoli, Gaetano; Lovero, Domenica; Tucci, Marco; Porta, Camillo; Mannavola, Francesco | |
| Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives | 1-gen-2021 | Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C. | |
| Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications | 1-gen-2022 | Lauricella, Eleonora; Mandriani, Barbara; Cavallo, Federica; Pezzicoli, Gaetano; Chaoul, Nada; Porta, Camillo; Cives, Mauro | |
| Beyond ras and braf: Her2, a new actionable oncotarget in advanced colorectal cancer | 1-gen-2021 | Guarini, C.; Grassi, T.; Pezzicoli, G.; Porta, C. | |
| Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors | 1-gen-2021 | Pezzicoli, Gaetano; Triggiano, Giacomo; Sergi, Maria Chiara; Mannavola, Francesco; Porta, Camillo; Tucci, Marco | |
| Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification | 1-gen-2023 | Rizzo, Mimma; Caliò, Anna; Brunelli, Matteo; Pezzicoli, Gaetano; Ganini, Carlo; Martignoni, Guido; Porta, Camillo Guglielmo Giuseppe | |
| Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma | 1-gen-2022 | Marconcini, Riccardo; Pezzicoli, Gaetano; Stucci, LUIGIA STEFANIA; Sergi, MARIA CHIARA; Lospalluti, Lucia; Porta, Camillo; Tucci, Marco | |
| DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition | 1-gen-2020 | Mannavola, Francesco; Pezzicoli, Gaetano; Tucci, Marco | |
| Il trattamento del carcinoma renale avanzato: un aggiornamento [The Treatment of Metastatic Renal Cell Carcinoma: An Update] | 1-gen-2023 | Pezzicoli, Gaetano; Ganini, Carlo; Re Sartò, Giulia Vanessa; Pirovano, Marta; Cosmai, Laura; Porta, Camillo | |
| IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma | 1-gen-2022 | Rizzo, Mimma; Varnier, Luca; Pezzicoli, Gaetano; Pirovano, Marta; Cosmai, Laura; Porta, Camillo | |
| Large extracellular vesicles—a new frontier of liquid biopsy in oncology | 1-gen-2020 | Pezzicoli, G.; Tucci, M.; Lovero, D.; Silvestris, F.; Porta, C.; Mannavola, F. | |
| Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer | 1-gen-2020 | Internò, Valeria; Tucci, Marco; Pezzicoli, Gaetano; Silvestris, Franco; Porta, Camillo; Mannavola, Francesco | |
| MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management | 1-gen-2022 | Rizzo, Mimma; Pezzicoli, Gaetano; Santoni, Matteo; Caliò, Anna; Martignoni, Guido; Porta, Camillo | |
| Playing the devil’s advocate: Should we give a second chance to mTOR inhibition in renal clear cell carcinoma? – ie strategies to revert resistance to mtor inhibitors | 1-gen-2021 | Pezzicoli, G.; Filoni, E.; Gernone, A.; Cosmai, L.; Rizzo, M.; Porta, C. | |
| Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations | 1-gen-2024 | Rizzo, Mimma; Pezzicoli, Gaetano; Ganini, Carlo; Carone, Luisa; Caliò, Anna; Brunelli, Matteo; Cosmai, Laura; Porta, Camillo | |
| Uterine carcinosarcoma: An overview | 1-gen-2021 | Pezzicoli, G.; Moscaritolo, F.; Silvestris, E.; Silvestris, F.; Cormio, G.; Porta, C.; D'Oronzo, S. |